Article
Author(s):
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Lawsuits Likely as Federal Authorities Roll Back Longstanding Vaccine Guidelines
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
Redefining Evidence: A Paradigm Shift to Unlock Access for Innovative Therapies
Beyond the Prescription: Pharma's Role in Digital Health Conversations
CSL to Layoff 15% of Employees, Close 22 US-based Plasma Centers
Skyhawk Therapeutics, Merck KGaA Strike Multi-Billion Dollar Deal to Advance RNA Therapies in Neurology